TD Cowen lowered the firm’s price target on Iqvia to $249 from $251 and keeps an Outperform rating on the shares. The analyst said we remain confident in IQV following 1Q where IQV’s commentary around not seeing weakness experienced by others was met with skepticism.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on IQV: